Resultados de la búsqueda 1281-1290 of 12275 for Tetracycline ointment

  1. Hematología - Ensayos clínicos

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

  2. Centro para Rehabilitación del Dolor - Ensayos clínicos

    The purpose of this study is to evaluate the hormonal profile related to opioid-induced hypogonadism (OIH) in chronic pain patients before and after ...

  3. Aceite de árbol de té - Mayo Clinic

    Las personas se pueden aplicar aceite del árbol de té sobre la piel para tratar diversas afecciones. Se cree que el aceite del árbol de té elimina los gérmenes ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to, in tissue, discover and validate DNA methylation markers (MDMs) for detection of invasive urothelial carcinoma of the bladder.

  5. Ensayos clínicos - Hematología

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  7. Oncología Quirúrgica de Mama y Melanoma de Rochester - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to evaluate the effectiveess of a new 3D ultrasound imaging technology combining B-mode, microvessel imaging, ...

  8. Brightcove-Orthopedic surgery home

    Brightcove-Orthopedic surgery home · [MÚSICA] · Tom Lutz, paciente: Mayo Clinic es un lugar absolutamente fantástico. · Dr. Alexander Shin, Cirugía ortopédica, ...

  9. Oncología (médica) - Ensayos clínicos

    This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...